117 related articles for article (PubMed ID: 17357059)
1. Killed but metabolically active Salmonella typhimurium: application of a new technology to an old vector.
Lankowski AJ; Hohmann EL
J Infect Dis; 2007 Apr; 195(8):1203-11. PubMed ID: 17357059
[TBL] [Abstract][Full Text] [Related]
2. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
[TBL] [Abstract][Full Text] [Related]
3. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
[TBL] [Abstract][Full Text] [Related]
4. Immune response induced by Salmonella typhimurium defective in ppGpp synthesis.
Na HS; Kim HJ; Lee HC; Hong Y; Rhee JH; Choy HE
Vaccine; 2006 Mar; 24(12):2027-34. PubMed ID: 16356600
[TBL] [Abstract][Full Text] [Related]
5. Attenuated Salmonella enterica serovar Typhimurium lacking the ZnuABC transporter confers immune-based protection against challenge infections in mice.
Pasquali P; Ammendola S; Pistoia C; Petrucci P; Tarantino M; Valente C; Marenzoni ML; Rotilio G; Battistoni A
Vaccine; 2008 Jun; 26(27-28):3421-6. PubMed ID: 18499306
[TBL] [Abstract][Full Text] [Related]
6. [Construction and characterization of Salmonella typhimurium SL7207 SifA- mutant strain].
Zhang XM; Jiao XA; Tang LH; Pan ZM; Yin YL
Wei Sheng Wu Xue Bao; 2005 Jun; 45(3):349-54. PubMed ID: 15989224
[TBL] [Abstract][Full Text] [Related]
7. Modulation of immune response in mice immunised with an inactivated Salmonella vaccine and gavaged with Andrographis paniculata extract or andrographolide.
Xu Y; Chen A; Fry S; Barrow RA; Marshall RL; Mukkur TK
Int Immunopharmacol; 2007 Apr; 7(4):515-23. PubMed ID: 17321475
[TBL] [Abstract][Full Text] [Related]
8. [Cloning and functional analysis of promoter pagC from attenuated Salmonella typhimurium].
Wang H; Zhao P; Zhang M; Zhu S; Qi Z
Wei Sheng Wu Xue Bao; 2003 Jun; 43(3):308-14. PubMed ID: 16279195
[TBL] [Abstract][Full Text] [Related]
9. Acquired immunity to Salmonella typhimurium and delayed (footpad) hypersensitivity in BALB/c mice.
Hormaeche CE; Fahrenkrog MC; Pettifor RA; Brock J
Immunology; 1981 Jul; 43(3):547-54. PubMed ID: 7019057
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
Qu D; Wang S; Cai W; Du A
Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
[TBL] [Abstract][Full Text] [Related]
11. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
[TBL] [Abstract][Full Text] [Related]
12. Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits.
Ashby D; Leduc I; Lauzon W; Lee BC; Singhal N; Cameron DW
J Immunol Methods; 2005 Apr; 299(1-2):153-64. PubMed ID: 15914198
[TBL] [Abstract][Full Text] [Related]
13. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
Negi VD; Singhamahapatra S; Chakravortty D
Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of Salmonella enterica Serovar Typhimurium by altering biological functions of murein lipoprotein and lipopolysaccharide.
Fadl AA; Sha J; Klimpel GR; Olano JP; Galindo CL; Chopra AK
Infect Immun; 2005 Dec; 73(12):8433-6. PubMed ID: 16299345
[TBL] [Abstract][Full Text] [Related]
15. Salmonella typhimurium grown in iron-rich media, inactivated with ferric chloride and adjuvanted with homologous bacterial DNA is potent and efficacious vaccine in mice.
Kumar D; Singh A
Vaccine; 2005 Dec; 23(48-49):5590-8. PubMed ID: 16098639
[TBL] [Abstract][Full Text] [Related]
16. A limited role for SsrA/B in persistent Salmonella Typhimurium infections in pigs.
Boyen F; Pasmans F; Van Immerseel F; Morgan E; Botteldoorn N; Heyndrickx M; Volf J; Favoreel H; Hernalsteens JP; Ducatelle R; Haesebrouck F
Vet Microbiol; 2008 Apr; 128(3-4):364-73. PubMed ID: 18068913
[TBL] [Abstract][Full Text] [Related]
17. Catecholate receptor proteins in Salmonella enterica: role in virulence and implications for vaccine development.
Williams PH; Rabsch W; Methner U; Voigt W; Tschäpe H; Reissbrodt R
Vaccine; 2006 May; 24(18):3840-4. PubMed ID: 16154248
[TBL] [Abstract][Full Text] [Related]
18. Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity.
Brockstedt DG; Bahjat KS; Giedlin MA; Liu W; Leong M; Luckett W; Gao Y; Schnupf P; Kapadia D; Castro G; Lim JY; Sampson-Johannes A; Herskovits AA; Stassinopoulos A; Bouwer HG; Hearst JE; Portnoy DA; Cook DN; Dubensky TW
Nat Med; 2005 Aug; 11(8):853-60. PubMed ID: 16041382
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines.
Husseiny MI; Hensel M
Vaccine; 2005 Apr; 23(20):2580-90. PubMed ID: 15780440
[TBL] [Abstract][Full Text] [Related]
20. IgA response of BALB/c mice to orally administered Salmonella typhimurium flagellin-displaying T2 bacteriophages.
Synnott A; Ohshima K; Nakai Y; Tanji Y
Biotechnol Prog; 2009; 25(2):552-8. PubMed ID: 19334277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
